Disruption of SDF-1–CXCR4 binding by the CXCR4 antagonist AMD3100 accelerates the development of diabetes in adoptive transfer models [18] and induces beta-cell apoptosis [43]. Here, CXCL12 is linked to diabetes mellitus.